Mazama Capital Management’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q3
Sell
-30,404
Closed -$4.67M 279
2015
Q2
$4.67M Buy
+30,404
New +$4.87M 0.94% 29
2014
Q4
Sell
-16,460
Closed -$2.31M 285
2014
Q3
$2.31M Sell
16,460
-24,752
-60% -$3.23M 0.59% 61
2014
Q2
$4.88M Buy
41,212
+20,739
+101% +$2.4M 1.3% 17
2014
Q1
$2.52M Buy
20,473
+440
+2% +$53.4K 2.29% 7
2013
Q4
$2.29M Buy
20,033
+1,879
+10% +$214K 1.13% 18
2013
Q3
$2.03M Buy
+18,154
New +$1.97M 1.11% 25

Other funds holding AMGN

Mazama Capital Management's AMGN Position: Q3 2015 in Review

Mazama Capital Management sold out of Amgen (AMGN) in Q3 2015, closing a stake of 30,404 shares — an estimated $4.67M sold.

Mazama Capital Management first reported a position in AMGN in Q3 2013 and held it in 6 quarters. The position peaked at $4.88M in Q2 2014. 1,381 funds tracked by Wall St. Rank hold AMGN as of Q3 2015.

  • Mazama Capital Management reported no remaining Amgen position as of Q3 2015 after selling out during the quarter.
  • Mazama Capital Management sold 30,404 Amgen shares in Q3 2015, an estimated $4.67M.
  • Mazama Capital Management first reported a position in Amgen in Q3 2013 and held it in 6 quarters.
  • Mazama Capital Management's Amgen position peaked at $4.88M in Q2 2014.
  • 1,381 funds tracked by Wall St. Rank held Amgen as of Q3 2015.

Based on Mazama Capital Management's 13F filing for Q3 2015, filed 13 Nov 2015.